Home › Bladder Cancer › Pennsylvania › Scranton
Bladder Cancer clinical trials in Scranton, PA
3 studies for Bladder Cancer are looking for participants at sites in and around Scranton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Geisinger Cancer Center Dickson City, Dickson City · 5 mi away
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Geisinger Cancer Center Dickson City, Dickson City · 5 mi away
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
Other studies in Scranton
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Colorectal Cancer5 studies
- Prostate Cancer5 studies
- Heart Failure4 studies
- Depression3 studies
- Pancreatic Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Esophageal Adenocarcinoma3 studies
- Stomach Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.